Marta Żołnowska

1.7k total citations
11 papers, 365 citations indexed

About

Marta Żołnowska is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Marta Żołnowska has authored 11 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pharmacology. Recurrent topics in Marta Żołnowska's work include Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Cannabis and Cannabinoid Research (5 papers). Marta Żołnowska is often cited by papers focused on Epilepsy research and treatment (8 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Cannabis and Cannabinoid Research (5 papers). Marta Żołnowska collaborates with scholars based in United States, United Kingdom and Spain. Marta Żołnowska's co-authors include Orrin Devinsky, Ian Miller, Rima Nabbout, Claire Roberts, Linda Laux, Stephen Wright, Vicente Villanueva, Dimitrios Arkilo, Mahnaz Asgharnejad and Dennis Dlugos and has published in prestigious journals such as Neurology, Nutrients and Epilepsia.

In The Last Decade

Marta Żołnowska

11 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Żołnowska United States	7	225	159	123	100	44	11	365
Chloe Verducci United States	6	178 0.8×	100 0.6×	89 0.7×	89 0.9×	38 0.9×	9	266
Kerstin Alexandra Klotz Germany	12	251 1.1×	105 0.7×	144 1.2×	109 1.1×	28 0.6×	41	367
Richard J. Huntsman Canada	10	86 0.4×	86 0.5×	52 0.4×	52 0.5×	21 0.5×	20	276
Giulia Iapadre Italy	10	212 0.9×	24 0.2×	115 0.9×	169 1.7×	31 0.7×	22	367
Alana C. Costa Brazil	10	148 0.7×	33 0.2×	31 0.3×	16 0.2×	35 0.8×	25	330
Hatice Aygün Türkiye	12	76 0.3×	20 0.1×	86 0.7×	51 0.5×	11 0.3×	44	387
Aleksandra Pastrak United States	8	51 0.2×	93 0.6×	28 0.2×	62 0.6×	31 0.7×	19	354
Dimitrios Arkilo United States	11	152 0.7×	16 0.1×	68 0.6×	93 0.9×	71 1.6×	26	305
Sunao Kaneko Japan	8	186 0.8×	40 0.3×	129 1.0×	176 1.8×	14 0.3×	8	402
Jinsook Kim South Korea	6	105 0.5×	17 0.1×	60 0.5×	153 1.5×	10 0.2×	9	285

Countries citing papers authored by Marta Żołnowska

Since Specialization

Citations

This map shows the geographic impact of Marta Żołnowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Żołnowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Żołnowska more than expected).

Fields of papers citing papers by Marta Żołnowska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Żołnowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Żołnowska. The network helps show where Marta Żołnowska may publish in the future.

Co-authorship network of co-authors of Marta Żołnowska

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Żołnowska. A scholar is included among the top collaborators of Marta Żołnowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Żołnowska. Marta Żołnowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Vandenplas, Yvan, Marta Żołnowska, Roberto Berni Canani, et al.. (2022). Effects of an Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides on Growth, Tolerability, Safety and Infection Risk in Infants with Cow’s Milk Protein Allergy: A Randomized, Multi-Center Trial. Nutrients. 14(3). 530–530. 27 indexed citations

Hahn, Cecil D., Yuwu Jiang, Vicente Villanueva, et al.. (2022). A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome (ELEKTRA). Epilepsia. 63(10). 2671–2683. 56 indexed citations

Hahn, Cecil D., Yuwu Jiang, Marta Żołnowska, et al.. (2021). Efficacy, Safety and Tolerability of Soticlestat (TAK-935/OV935) as Adjunctive Therapy in Pediatric Patients with Dravet Syndrome and Lennox-Gastaut Syndrome (ELEKTRA) (4234). Neurology. 96(15_supplement). 8 indexed citations

Hahn, Cecil D., Marta Żołnowska, Dimitrios Arkilo, et al.. (2021). Long-Term Soticlestat Treatment in Patients with Developmental and/or Epileptic Encephalopathies in the ENDYMION Ongoing Open-Label Extension Study (4197). Neurology. 96(15_supplement). 1 indexed citations

Scheffer, Ingrid E., Jonathan J. Halford, Ian Miller, et al.. (2021). Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial. Epilepsia. 62(10). 2505–2517. 60 indexed citations

Checketts, Daniel, Eduardo Dunayevich, Boudewijn Gunning, et al.. (2021). Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials. Epilepsia. 62(9). 2218–2227. 18 indexed citations

Devinsky, Orrin, Rima Nabbout, Ian Miller, et al.. (2018). IP 110. Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet’s Syndrome: Results of an Open-Label Extension Trial (GWPCARE5). Neuropediatrics. 3 indexed citations

Miller, Ian, Orrin Devinsky, Rima Nabbout, et al.. (2018). Maintenance of Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Dravet Syndrome (DS): Results of the Open-Label Extension (OLE) Trial (GWPCARE5) (S19.003). Neurology. 90(15_supplement). 6 indexed citations

Devinsky, Orrin, Rima Nabbout, Ian Miller, et al.. (2018). Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial. Epilepsia. 60(2). 294–302. 178 indexed citations

10.

Białek, Marzena, et al.. (2017). Synthesis and olefin homo- and copolymerization behavior of new vanadium complexes bearing [OSSO]-type ligands. Reaction Kinetics Mechanisms and Catalysis. 122(1). 259–273. 4 indexed citations

11.

Lutosławska, Grażyna, et al.. (2006). Plasma proinsulin, C-peptide and sex hormone concentrations in regularly menstruating premenopausal females with ovulatory and anovulatory menstrual cycles.. PubMed. 46(1). 138–42. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact